The COVID-19 pandemic has affected design and conduct of all kinds of clinical trials, not only the specific areas of vaccines and therapeutics directly related to SARS-CoV-2 but also in other major therapeutic areas such as oncology/cancer treatment. This presentation provides three different perspectives on this subject: 

1. The non-profit perspective that is trying to understand the impact of COVID-19 on recruiting patients for cancer studies
2. The pharma perspective on performing therapeutic and vaccine trials
3. The lab perspective on designing and executing COVID-19 targeted therapeutic and vaccine trials

Download presentation to learn more.